• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Arcellx, Inc. - Common Stock (NQ:ACLX)

    67.97 -0.54 (-0.79%)
    Streaming Delayed Price Updated: 2:39 PM EST, Jan 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 387,364
    Open 68.61
    Bid (Size) 67.72 (100)
    Ask (Size) 68.20 (400)
    Prev. Close 68.51
    Today's Range 67.00 - 69.05
    52wk Range 47.86 - 94.07
    Shares Outstanding 48,358,981
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Small-Cap M&A Boom of 2026: How $440 Billion in Dry Powder and Rate Cuts Are Remaking the Market
    As of January 27, 2026, the financial landscape has undergone a dramatic transformation. After a prolonged "deal winter" that chilled the markets through 2023 and much of 2024, the small-cap sector is... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
    From Arcellx, Inc.
    Via Business Wire

    Performance

    YTD
    +7.3%
    +7.3%
    1 Month
    +4.4%
    +4.4%
    3 Month
    -22.3%
    -22.3%
    6 Month
    -2.9%
    -2.9%
    1 Year
    +8.0%
    +8.0%

    More News

    Read More
    News headline image
    Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    4 Analysts Assess Arcellx: What You Need To Know ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    News headline image
    Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx Provides Third Quarter 2025 Financial Results
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    (ACLX) - Analyzing Arcellx's Short Interest ↗
    Via Benzinga
    News headline image
    In-Depth Examination Of 14 Analyst Recommendations For Arcellx ↗
    Via Benzinga
    News headline image
    Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx (ACLX) Q2 Revenue Drops 72% ↗
    Via The Motley Fool
    News headline image
    Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers ↗
    Via Benzinga
    News headline image
    The FDA Shake-Up Continues, And Could Impact Genetic Medicines ↗
    Via Investor's Business Daily
    Topics Government
    News headline image
    Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx Provides First Quarter 2025 Financial Results and Business Highlights
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference
    From Arcellx, Inc.
    Via Business Wire
    News headline image
    Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention ↗
    Via Benzinga
    News headline image
    Arcellx Stock Earns 82 Relative Strength Rating ↗
    Via Investor's Business Daily

    Frequently Asked Questions

    Is Arcellx, Inc. - Common Stock publicly traded?
    Yes, Arcellx, Inc. - Common Stock is publicly traded.
    What exchange does Arcellx, Inc. - Common Stock trade on?
    Arcellx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Arcellx, Inc. - Common Stock?
    The ticker symbol for Arcellx, Inc. - Common Stock is ACLX on the Nasdaq Stock Market
    What is the current price of Arcellx, Inc. - Common Stock?
    The current price of Arcellx, Inc. - Common Stock is 67.97
    When was Arcellx, Inc. - Common Stock last traded?
    The last trade of Arcellx, Inc. - Common Stock was at 01/28/26 02:39 PM ET
    What is the market capitalization of Arcellx, Inc. - Common Stock?
    The market capitalization of Arcellx, Inc. - Common Stock is 3.29B
    How many shares of Arcellx, Inc. - Common Stock are outstanding?
    Arcellx, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.